Stem cells to prevent bile duct problems after liver transplant
Part of Digestive system clinical trials.
This study tests whether stem cells from donated fat tissue can help prevent bile duct problems after a living-donor liver transplant. It is for adult patients who are listed for a transplant and will receive a liver from a living donor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are on the waiting list for a liver transplant.
- You are planning to receive a liver from a living donor, not a deceased donor.
- You are able to talk with the study team and understand the study procedures.
- You do not have an uncontrolled infection anywhere in your body.
- Your body mass index (BMI) is below 40.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a special temporary stent that breaks down over time to help open a narrowed bile duct after a liver transplant. It may help avoid long-term plastic stents or additional surgery.
This trial tests whether fenofibrate can prevent primary sclerosing cholangitis (PSC) from coming back after a liver transplant. It is for adults who had a liver transplant for PSC between 1 and 7 years ago and have certain risk factors.
This trial tests whether using amniotic tissue during bile duct connection surgery can improve outcomes for people receiving a liver transplant from a living donor.
This study tests whether stem cells from donated umbilical cords can help people with end-stage liver disease. Doctors want to see if the way the cells are given (like through a vein or artery) affects how well they work.
This trial tests if a therapy made from stem cells (called MSC-EVs) can help patients recover from severe liver failure after a liver transplant. It is for people who had a sudden worsening of chronic liver disease and needed a new liver.
This early-stage trial tests umbilical cord “mesenchymal” stem cells in people with liver scarring (cirrhosis) that is caused by hepatitis B. It may help improve liver function and related complications, but it is mainly designed to check safety and how well the treatment works.
Hear when a new Liver Transplant; Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.